Harold H. Fox

Partner

• hfox@steptoe.com
• vCard
• Washington Office

Harold H. Fox is a partner in the Washington office of Steptoe & Johnson LLP, where he is a member of the Intellectual Property group.

Dr. Fox's intellectual property practice covers strategic intellectual property counseling, including strategic patent advice to clients in the context of patent enforcement actions, patent portfolio development, product life-cycle management and intellectual property portfolio evaluations.  He is experienced in all areas of chemistry, biotechnology, pharmaceuticals, biologics, nanotechnology, physics, chemical engineering, mechanical engineering, medical devices, business methods, and materials science.  Additionally, he has addressed intellectual property issues in government contracts and handled trademark and domain name issues.

He regularly assists clients in patent drafting and prosecution, patent interferences, patent infringement and validity studies, client counseling projects, advising on patent litigation strategy, and handling due-diligence investigations.  Specifically, Dr. Fox regularly renders validity/invalidity opinions, infringement/noninfringement opinions, and freedom-to-operate opinions, drafts patent applications, licenses, research agreements, development agreements, and licenses, and conducts due-diligence, and pre-litigation studies.  His patent litigation experiences include advising and representing clients in U.S. District Court litigation as well as Section 337 patent infringement investigations before the US International Trade Commission.

Dr. Fox has published numerous research articles in the fields of inorganic chemistry, physical chemistry, organic chemistry, organometallic chemistry, catalysis, polymer chemistry, materials chemistry, electrochemistry, nonlinear optics, glass and ceramic materials, conjugated/conductive polymers, and theoretical chemistry in publications such as Science, the Journal of the American Chemical Society, the Journal of Organic Chemistry, Macromolecules, and Organometallics.

Noteworthy

• Named one of the top 50 under 45 by IP Law & Business for 2008
  

Select News & Events

• The American Lawyer Quotes Harold Fox on Biologics Patent Litigation
• "Intellectual Property Case Law Update and Resulting Litigation Issues", October 8, 2008, Third Annual Biotech Institute and Regional CLE Workshop
• Harold Fox Named in IP Law & Business Top 50 Under 45
• Nanotechnology in Food and Agriculture, June 7, 2006
• Harold Fox Speaks at PAT Conference, June 27, 2005
• Steptoe's New Technology Partner

Selected Publications

• Intellectual Property Advisory - Patentability of Methods Generally Upheld
  June 29, 2010
• Intellectual Property Advisory - Induced Infringement Can Be Shown Without Direct Evidence that Accused Infringer Knew of Asserted Patent
  February 15, 2010
• Intellectual Property Advisory - Federal Circuit Affirms Patent Term Adjustment Calculation
  January 8, 2010
• Intellectual Property Advisory - Recent Bills (Re)Introduced in Congress Directed to Pharmaceutical Companies
  March 30, 2009
• Intellectual Property Advisory - FDA Denies 30-Month Stay of Approval of Certain ANDAs Under the QI-Act
  March 23, 2009
• Intellectual Property Advisory - Amendments to Chinese Patent Law Affecting Pharmaceutical and Biotech Companies
  February 16, 2009
• Intellectual Property Advisory - New Requirements for Submission of Bioequivalence Data for Generic Drug Applications
  January 28, 2009

Professional Affiliations

• American Chemical Society